IP Verse

Method Of Treating Cancer Using Immune Checkpoint Inhibitor - EP3322731

PATENT ANALYSIS

Patent Details

Grant Date
Jan 13, 2021
Company
BRISTOL-MYERS SQUIBB COMPANY
Oppositions

APPLEYARD LEES IP LLP / FLECK BARBARA

BIONTECH SE

GREINER, ELISABETH

ISA PHARMACEUTICALS B.V

KRAUS & LEDERER PARTGMBB

MAIWALD GMBH

MERCK SHARP & DOHME LLC

PATENT BOUTIQUE LLP

REGENERON PHARMACEUTICALS, INC.

More patents of Bristol-Myers Squibb Company

EP3631454

EP3559230

EP3227333

Want to monitor this patent?

Feel free to send us a message here and we will get back to you